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Abstract. The expression of cytochrome P-450 (b+e) and glutathione transferase
(Ya+Yc) genes has been studied as a function of development in rat liver. The levels of
cytochrome P-450 (b+e) mRNAs and their transcription rates are too low for detection in
the 19-day old fetal liver before or after phenobarbitone treatment. However, glutathione 
transferase (Ya+Yc) mRNAs can be detected in the fetal liver as well as their induction
after phenobarbitone treatment can be demonstrated. These mRNAs contents as well as 
their inducibility with phenobarbitone are lower in maternal liver than that of adult non- 
pregnant female rat liver. Steroid hormone administration to immature rats blocks 
substantially the phenobarbitone mediated induction of the two mRNA families as well as 
their transcription. It is suggested that steroid hormones constitute one of the factors
responsible for the repression of the cytochrome P-450 (b+e) and glutathione transferase
(Ya+Yc) genes in fetal liver. 
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Introduction 
 
It is known that the cytochrome P-450 dependent mixed function oxygenase 
activities are very low in fetal liver and increase rapidly soon after birth. 
Phenobarbitone fails to induce cytochrome P-450 in fetal liver, although 3-methyl- 
cholanthrene is capable of a selective but small level of induction. It has also been 
shown that phenobarbitone readily crosses the placental barrier and accumulates in 
the fetal liver to almost the same concentration observed in the adult liver. 
Phenobarbitone is quite effective in inducing cytochrome P-450 soon after birth 
(Waddel and Mirkin, 1971; Guenthner and Mannering, 1977; Cresteil et al., 1979; 
Nebert et al., 1982). 
Glutathione-S-transferase, another important enzyme family-of the drug meta- 
bolizing pathway, has been shown to be present at 10–20% of the adult levels in 
fetal rat liver. The susceptibility of this enzyme family for induction at the fetal stage 
has not been well studied, except that phenobarbitone induces this enzyme system
2–3-fold after birth and the extent of induction remains constant throughout
development (Hales and Neims, 1976; Neims et al., 1976). 
The molecular mechanism of regulation of expression of these two gene systems
during development has not been well studied, except for a report that phenol-
barbitone fails to induce cytochrome P-450b or e mRNA in 10- or 19-day old fetal
liver but detectable levels of induction are seen on day 22 (Giachelli and
Omiecinski, 1986). In the present study, the induction of cytochrome P-450 (b+e)
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and glutathione transferase (Ya+Yc) mRNAs by phenobarbitone in fetal, pup and
adult rat livers was examined using cloned cDNA hybridization probes. The run-off
transcription rates with isolated nuclei were measured. The effects of circulating
steroid hormones on these parameters were also studied and the suggestion is made
that these hormones constitute one of the factors responsible for maintaining these
genes in the repressed state in fetal liver. 
 
Experimental procedures 
 
Treatment  of  animals 
 
Pregnant rats (200 g body weight) of the Institute strain were given one, two or
three intraperitoneal injections of phenobarbitone (8 mg/100 g body weight) starting
on day 17 or 19. The animals were killed 12h after the last injection. Single
injections of steroid hormones were given intraperitoneally at a dose of 1 mg/100 g,
15 min before the drug administration. 
 
Quantification of cytochrome P-450(b+e) and glutathione transferase (Ya+Yc)
mRNA 
 
Polysomal RNA was isolated from the pooled livers of rats by the magnesium 
precipitation procedure of Palmiter (1974). Poly (A)-containing RNA was isolated
using oligo-dT cellulose chromatography. Specific mRNA concentrations were 
estimated by dot blot hybridization using specific nick-translated cloned cDNA 
probes. In these studies 500 ng to 1 µg of poly (A)-containing RNA or 10-20 µg of 
total polysomal RNA was loaded onto nitrocellulose filters. In northern blot 
experiments 10 µg of polysomal RNA was used. The dot blot and northern blot 
hybridizations were carried out as described by Thomas (1980). Agarose (1 %, w/v)- 
formaldehyde gels were used for RNA analysis (Maniatis et al., 1982). The probes
used were inserts from the plasmids pP-450 91 (Ravishankar and Padmanaban, 
1985) and pGST 19 (Francis et al., 1986) for quantifying cytochrome P-450(b + e)
and glutathione transferase (Ya+Yc) mRNAs respectively. The probes covered
more than 2/3 of cytochrome P-450e and glutathione transferase Ya subunit 
mRNAs respectively from 3'ends. Cytochrome P-450 e and b mRNAs as well as
glutathione transferase Yc and Ya subunit mRNAs have extensive regions of 
homology (Mizukami et al., 1983; Pickett et al., 1984). Albumin mRNA was 
quantified with the albumin cDNA probe (Sathyabhama et al., 1986). Nick
translation was carried out in the presence of [α32-P]dCTP and a labelling of 
5 × 107 to 108 cpm/µg DNA was routinely obtained. After carrying out the 
hybridization and washing procedures, the blots were exposed to X-ray films and 
the corresponding dots were punched out from the nitrocellulose blots and radio- 
activity measured using 0·5% (w/v) PPO in toluene as the scintillation fluid. Linear 
responses were obtained in the concentration range up to 1·5 µg for poly (A)-
containing RNA and 20 µg for total polysomal RNA. The experiments were
repeated 4 times and the pattern of results was reproducible. However, the absolute
radioactivity in the dots varied between experiments depending on the specific
activity of the probe used. 
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Cell- free  nuclear  transcription
 
Nuclei were isolated from the livers of rats given the various treatments and cell-
free transcription was carried out in the presence of [α32-P] UTP as described by
Ravishankar and Padmanaban (1985) based on the reaction conditions given by 
Guertin et al. (1983). The RNA transcribed in vitro (107 cpm) was hybridized to 
filters containing pP-450 91 or pGST 19 or pAlb 6 DNA. About 5 µg of the DNAs 
were loaded on filters. After hybridization and washing the filters were dried and 
radioactivity measured. Addition of α-amanitin (1 µg/ml) to the transcription 
mixture was found to inhibit total transcription by about 50%, but hybridization to 
the cloned probes used was found to be inhibited by 96–98%. Non-specific hybridiza- 
tion to pBR 322 DNA was of the order of 10% of specific hybridization and this 
value was subtracted in the final data presented. 
 
Results 
 
The inducibility of cytochrome P-450 (b + e) and glutathione transferase (Ya+Yc) 
mRNAs by phenobarbitone in fetal, pup and adult livers were examined by dot blot 
hybridization and the quantitative values are presented in table 1. The results 
indicate that detectable levels of cytochrome P-450(b + e) mRNA are not present in
control fetal liver. The mRNAs can be detected in the livers of 5-day old pups, 
maternal and non-pregnant female adult livers. Phenobarbitone administration to 
the mother fails to induce these mRNAs in fetal liver. This is irrespective of whether 
the animal has received 1, 2 or 3 injections of the drug. There is about 10-12-fold
induction in the 5-day old pup and pregnant mother. 
 
Table 1. Cytochrome P-450 and glutathione transferase (Ya+Yc) mRNA
contents in rat liver as a function of development. 
 
 
Nineteen-day old pregnant rats as well as the other groups received a single 
injection of phenobarbitone and the animals were killed after 12 h. Poly (A)- 
containing RNA (1 µg) isolated from the magnesium-precipitated liver 
polyribosomes was loaded onto nitrocellulose filters and hybridized with the 
nick-translated probes. The values presented are those obtained in a typical 
experiment. 
ND, Not detectable. 
 
The induction is nearly 20-fold in the non-pregnant adult female. Unlike
cytochrome P-450 (b+e) mRNAs, glutathione transferase (Ya+Yc) mRNAs can be
detected in control fetal livers. These mRNA concentrations increase 1·5-, 2·5- and 4-
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fold in control pup, pregnant and non-pregnant female livers respectively. 
Phenobarbitone administration results in a small but consistent pattern of 
induction of glutathione transferase (Ya+Yc) mRNAs in fetal liver. The induction
is around 1·5-fold in pups, 2– and 2·5-fold in the pregnant and non-pregnant adult 
females respectively 12 h after a single injection of phenobarbitone. The northern 
blot presented in figure 1 confirms the pattern of data presented in table 1. In
particular, it is clear that glutathione transferase (Ya+Yc) mRNAs are present in
the fetal liver and are induced by phenobarbitone (figure 1, lanes 3 and 6). It may be 
pointed out that for northern blot analysis, RNA was isolated from animals which 
had received 3 injections of the drug and the glutathione transferase (Ya + Yc) 
mRNA induction obtained is nearly 7–10-fold of the levels observed in control rats. 
In separate hybrid selection experiments, pGST-19 has been found to pick up 
mostly Ya mRNA and therefore these results would mostly reflect changes in the 
concentration of Ya mRNA. On the basis of the mobility of the size markers, it 
appears that these have a size range of 900±50 nucleotides which is around the 
value reported earlier (Pickett et al., 1983). Giachelli and Omiecinski (1986) have 
 
 
Figure 1. Northern blot analysis of glutathione transferase (Ya+Yc) mRNAs during
development and phenobarbitone treatment. The animals received 3 injections of 
phenobarbitone one each at 24 h intervals. The first injection was given to 17-day old 
pregnant rats and the maternal and fetal livers were isolated on day 19. Total polysomal 
RNA (10 µg) was subjected to northern blot analysis using nick-translated fragment from 
pGST-19 as probe. 28 S and 18 S ribosomal RNAs, globin mRNA and tRNA were used as 
size markers. Lanes 1-3, Phenobarbitone treated; lanes 4-6 control; lanes 1 and 4, adult
female liver; lanes 2 and 5, maternal liver; lanes 3 and 6, fetal liver. 
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reported that the size of cytochrome P-450e mRNA remains around 1·8 kb
throughout development. 
In view of the bindings that phenobarbitone fails to induce cytochrome P- 
450(b+e) mRNAs and induces glutathione transferase (Ya+Yc) mRNAs to a lower
extent in fetal livers than in the adult and that the induction of these mRNA
families in the pregnant mother is lower than that of the non-pregnant female, the 
effects of circulating steroid hormones on the phenobarbitone-mediated induction 
of these mRNAs were investigated. Figure 2 indicates that estradiol and
progesterone administration block significantly the phenobarbitone mediated
induction of cytochrome P-450(b+e) mRNAs in the 5-day old pup. Surprisingly,
the hormones fail to block the induction in adult male rats. In fact, a certain level of 
synergism is seen between the hormones and the drug. Detailed quantitative results 
for cytochrome P-450(b+e) and glutathione transferase (Ya+Yc) mRNAs are
presented in table 2. The hormones estradiol, progesterone, testosterone and 
dexamethasone inhibit the phenobarbitone-mediated induction of both mRNA
families by 50-70% in the 5-day old pup liver. 
 
 
Figure 2. Dot blot analysis of cytochrome P-450(b+e) mRNAs after phenobarbitone and
steroid treatments. Five-day old pups and adult male rats received single injections of 
phenobarbitone along with estradiol and progesterone. Poly (A) containing RNA (1 µg) 
was used for the dot blot analysis using nick-translated fragment from pP-450 91 as probe.
Lane A (pup): (1), control; (2), phenobarbitone; (3), phenobarbitone + estradiol; (4),
phenobarbitone + progesterone. Lane B (adult): (1), control; (2), phenobarbitone + estradiol; 
(3), phenobarbitone + progesterone; (4), phenobarbitone. 
 
Table 2. Effect of steroid hormones on the induction of cytochrome P-450 (b+e) and glutathione
transferase (Ya+Yc) mRNAs by phenobarbitone. 
 
The treatment conditions and other experimental details are as described in the text and table 1. The
results presented are those obtained in a typical experiment 
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Figure 3. Transcription rates of cytochrome P-450(b+e) and glutathione transferase
(Ya +Yc) mRNAs as a function of development. The nuclei isolated from the Rivers of rats 
at different developmental stages were incubated for 45 min at 250C and other components 
with [α-32P]UTP and the transcribed RNA was hybridized to the probes. The total RNA 
transcribed, expressed in cpm in the case of each nuclear preparation, is indicated in
parenthesis. The specific transcription rates presented as bars are an average from two
independent experiments and are expressed as ppm of RNA hybridized/kb of the probe
used. The other details are given in the text, (C), Control; (PB), phenobarbitone,, (ND), not
detectable. 
 
The results presented in figure 3 indicate that the total RNA transcription rates 
obtained for fetal and pup livers is consistency around 50% of the adult livers, In 
the case of cytochrome P-450(b+e) mRNAs, phenobarbitone administration results
in about 5-, 10- and 20-fold increase in transcription rates for pup, pregnant and 
non-pregnant livers, Transcription of these mRNAs cannot be detected in control 
or phenobarbitone-treated fetal liver nuclei, In the case of glutathione transferase
(Ya+Yc) mRNAs, significantly level of transcription is detectable in control fetal liver
nuclei. With development, this increases by nearly 2-fold in the adult. Phenobarbitone
administration results in a small but consistency detectable increase in the
transcription rates in the fetal liver nuclei. The increase obtained with the pup,
pregnant and non-pregnant liver nuclei is less than 2-fold of the values obtained
with control animals, 12 h after a single injection of the drug. 
Since estradiol and progesterone significancy inhibited the induction of
cytochrome P-450(b+e) mRNAs and glutathione transferase (Ya+Yc) mRNAs in
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5-day old pup livers, the run-off transcription rates were also measured under these
conditions. The results presented in figure 4 indicate that the two hormones tested 
inhibit the phenobarbitone-mediated increase in the transcription rates of the two
mRNA families by 50-60%. It is of interest to point out that albumin mRNA
transcription rates measured under these conditions also show significant changes.
First of all, phenobarbitone administration per se decreases albumin transcription 
rate in the pup. Estradiol as well as testosterone treatments, further decrease the
albumin mRNA transcription rates. The albumin mRNA transcription rate
observed in the normal pup is around 40% of that seen with the adult (data not 
presented). It should, however, be pointed out that none of the treatments affects 
total RNA transcription rates to any significant extent. 
 
 
 
Figure 4. Effect of steroid hormones on the phenobarbitone-mediated increase in
transcription rates of cytochrome P-450(b+e), glutathione transferase (Ya+Yc) and
albumin mRNAs in pup liver. Nuclei were isolated from the livers of pups given the
different treatments. The experimental details are given in figure 3 and text. The values
depicted are an average obtained from two independent experiments. (C), Control, (PB),
phenobarbitone; (E), estrogen; (T), testosterone.
 
Discussion
 
Several interesting features of developmental regulation of the hepatic cytochrome
P-450(b+e) and glutathione transferase (Ya+Yc) gene systems are apparent from
this study. First of all, detectable levels of expression of the cytochrome P-450(b + e)
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mRNAs in control or phenobarbitone-treated 19-20-day old fetal livers are not 
manifest, confirming the report of Giachelli and Omiecinski (1986). However, 
glutathione transferase (Ya+Yc) mRNAs are expressed as well as induced in fetal
livers. 
Steroid hormones appear to exert a negative control in regulating the expression 
of both cytochrome P-450(b+e) and glutathione transferase (Ya+Yc) mRNAs in
fetal liver. The poor or non-expression of the former and the lower level of
expression of the latter gene systems in fetal liver in the presence or absence of the 
inducer, the inhibitory effects of the steroid hormones on phenobarbitone mediated 
induction of the two mRNA families in the immature animal and the lower levels of 
these mRNAs in the drug-treated pregnant mother compared to the non-pregnant 
adult female, all point to the role of circulating steroid hormones in exerting a 
negative control on the expression of these two gene systems in fetal and pregnant 
rat livers. It has not been possible to examine the effect of steroid hormones on 
cytochrome P-450(b+c) gene transcription directly in fetal liver in view of poor
expression. The possibility of factors in the fetomaternal environment suppressing 
the phenobarbitone-mediated induction of the drug-metabolizing enzymes in fetal 
liver has been suggested by Guenthner and Mannering (1977). Further studies are 
needed to examine the hormone-dependent changes in the expression of these genes 
during different phases of the estrous cycle in non-pregnant female adult rats. 
It is also clear that the responsiveness of the gene involved for interaction with 
the environment also changes during development. For example, in the adult male
the steroid hormones fail to repress the phenobarbitone-mediated induction of these 
mRNAs. We have recently shown that dexamethasone inhibits phenobarbitone- 
mediated increase in the transcription of cytochrome P-450(b+e) genes both in
adult and pup livers. However, dexamethasone inhibits the drug mediated induction 
of cytochrome P-450(b + e) mRNAs only in pup livers, but actually shows 
synergism with the drug in adult livers (table 2; Venkateswara Rao et al., 1990). 
Thus, development dependent post-transcriptional mechanisms are also involved in 
determining the ultimate levels of the functional mRNA and perhaps of the protein 
species as well. This is further indicated by the lack of a strict correlation between 
changes in transcription rates and mRNA contents under different developmental 
and physiological states. 
Two other features of this study are of interest. One is that all the 4 steroid
hormones examined share the ability to inhibit phenobarbitone-mediated increase
in the transcription of cytochrome P-450(b+e) and glutathione transferase
(Ya+Yc) genes. Steroid receptors belong to a super family and are related
structurally. The DNA consensus elements, involved in receptor binding are also
similar, but distinct identity is maintained in mediating transcriptional activation by 
the individual steroids (Evans, 1988; Green and Chambon, 1988). However, the
DNA consensus elements involved in mediating the negative modulatory effects of 
steroids have not been well characterized. The negative glucocorticoid receptor
element does not appear to share much of homology with the positive element or
with the negative elements detected in different gene systems (Sakai et al., 1988). It 
is possible that the negative steroid elements are degenerate and recognise more
than one steroid receptor in vitro. The second feature is that the steroids used
repress the expression of all the 3 gene systems, namely cytochrome P-450(b+ e),
glutathione transferase (Ya+Yc) and albumin in pups. All these 3 genes are poorly 
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expressed in the fetal liver. Thus, the role of steriods as negative modulators of the
expression of major liver proteins in fetal liver is indicated and would need further
investigation. 
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